Thrombocythemia Myelofibrosis (PET-MF)
2 clinical trials · Condition
◉ Watch Thrombocythemia Myelofibrosis (PET-MF)
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for INC424, Ruxolitinib (NCT04745637) | Novartis Pharmaceuticals |
Track Thrombocythemia Myelofibrosis (PET-MF) automatically
Every clearance here is in the API, with alerts when new ones post.